aTYR PHARMA INC
ATYR· Nasdaq
ATYRaTYR PHARMA INC
Filed Nov 14, 2018 · 10-Q · 45 days after period end · 0001564590-18-029559
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$7.11M | -$11.19M | -$13.82M | -$11.33M |
| EPS Diluted | -$3.33 | -$0.43 | -$0.58 | -$0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 14, 2018 · 45 d after period end
